azd3965 and Neuroblastoma

azd3965 has been researched along with Neuroblastoma* in 1 studies

Other Studies

1 other study(ies) available for azd3965 and Neuroblastoma

Article	Year
Catastrophic ATP loss underlies a metabolic combination therapy tailored for Proceedings of the National Academy of Sciences of the United States of America, 2021, 03-30, Volume: 118, Issue:13 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Basigin; Cell Line, Tumor; Cell Proliferation; Electron Transport Complex I; Gene Amplification; Humans; Mice; Mitochondria; Monocarboxylic Acid Transporters; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phenformin; Pyrimidinones; Symporters; Thiophenes; Xenograft Model Antitumor Assays	2021

Article

Year

Catastrophic ATP loss underlies a metabolic combination therapy tailored for

Proceedings of the National Academy of Sciences of the United States of America, 2021, 03-30, Volume: 118, Issue:13

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Basigin; Cell Line, Tumor; Cell Proliferation; Electron Transport Complex I; Gene Amplification; Humans; Mice; Mitochondria; Monocarboxylic Acid Transporters; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phenformin; Pyrimidinones; Symporters; Thiophenes; Xenograft Model Antitumor Assays

2021